Advances in the treatment of colorectal cancer

Yoshihiko Maehara, S. Ohno, S. Tomisaki, Y. Kakeji, A. Watanabe, H. Baba, Y. Adachi, Y. Ichiyoshi, D. Korenaga, K. Sugimachi

Research output: Contribution to journalArticle

Abstract

Colorectal cancer is one of the most serious diseases of our time. Recent progress in its treatment is reviewed in this paper. There are many approaches for treating colorectal cancer; extended surgery to function-preserving surgery. The aim of surgical treatment is to excise the tumor completely, so extended surgery has been performed for curative resection of colorectal cancer. However, the quality of life (QOL) of the patients has been extremely impaired. In recent years, surgical treatments for avoiding colostomy, and urinary and sexual difficulties have been widely carried out, and QOL of the patients could be maintained in the postoperative period. Stage oriented therapy is accepted as the concept of surgical treatment of colorectal cancer. For further improving the clinical results of colorectal cancer, we advocated 'type-oriented therapy' which is based on the biological characteristics of colorectal cancer, by determining i.e., p53 abnormalities of cancer cells, serum p53 antibodies, micrometastasis in the bone marrow and/or sensitivity to anticancer drugs.

Original languageEnglish
Pages (from-to)517-528
Number of pages12
JournalJapanese Journal of Cancer and Chemotherapy
Volume23
Issue number5
Publication statusPublished - May 31 1996

Fingerprint

Colorectal Neoplasms
Therapeutics
Quality of Life
Neoplasm Micrometastasis
Colostomy
Postoperative Period
Neoplasms
Bone Marrow
Antibodies
Serum
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Maehara, Y., Ohno, S., Tomisaki, S., Kakeji, Y., Watanabe, A., Baba, H., ... Sugimachi, K. (1996). Advances in the treatment of colorectal cancer. Japanese Journal of Cancer and Chemotherapy, 23(5), 517-528.

Advances in the treatment of colorectal cancer. / Maehara, Yoshihiko; Ohno, S.; Tomisaki, S.; Kakeji, Y.; Watanabe, A.; Baba, H.; Adachi, Y.; Ichiyoshi, Y.; Korenaga, D.; Sugimachi, K.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 23, No. 5, 31.05.1996, p. 517-528.

Research output: Contribution to journalArticle

Maehara, Y, Ohno, S, Tomisaki, S, Kakeji, Y, Watanabe, A, Baba, H, Adachi, Y, Ichiyoshi, Y, Korenaga, D & Sugimachi, K 1996, 'Advances in the treatment of colorectal cancer', Japanese Journal of Cancer and Chemotherapy, vol. 23, no. 5, pp. 517-528.
Maehara Y, Ohno S, Tomisaki S, Kakeji Y, Watanabe A, Baba H et al. Advances in the treatment of colorectal cancer. Japanese Journal of Cancer and Chemotherapy. 1996 May 31;23(5):517-528.
Maehara, Yoshihiko ; Ohno, S. ; Tomisaki, S. ; Kakeji, Y. ; Watanabe, A. ; Baba, H. ; Adachi, Y. ; Ichiyoshi, Y. ; Korenaga, D. ; Sugimachi, K. / Advances in the treatment of colorectal cancer. In: Japanese Journal of Cancer and Chemotherapy. 1996 ; Vol. 23, No. 5. pp. 517-528.
@article{e45f1554c44d4e6e8537570107476bfb,
title = "Advances in the treatment of colorectal cancer",
abstract = "Colorectal cancer is one of the most serious diseases of our time. Recent progress in its treatment is reviewed in this paper. There are many approaches for treating colorectal cancer; extended surgery to function-preserving surgery. The aim of surgical treatment is to excise the tumor completely, so extended surgery has been performed for curative resection of colorectal cancer. However, the quality of life (QOL) of the patients has been extremely impaired. In recent years, surgical treatments for avoiding colostomy, and urinary and sexual difficulties have been widely carried out, and QOL of the patients could be maintained in the postoperative period. Stage oriented therapy is accepted as the concept of surgical treatment of colorectal cancer. For further improving the clinical results of colorectal cancer, we advocated 'type-oriented therapy' which is based on the biological characteristics of colorectal cancer, by determining i.e., p53 abnormalities of cancer cells, serum p53 antibodies, micrometastasis in the bone marrow and/or sensitivity to anticancer drugs.",
author = "Yoshihiko Maehara and S. Ohno and S. Tomisaki and Y. Kakeji and A. Watanabe and H. Baba and Y. Adachi and Y. Ichiyoshi and D. Korenaga and K. Sugimachi",
year = "1996",
month = "5",
day = "31",
language = "English",
volume = "23",
pages = "517--528",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "5",

}

TY - JOUR

T1 - Advances in the treatment of colorectal cancer

AU - Maehara, Yoshihiko

AU - Ohno, S.

AU - Tomisaki, S.

AU - Kakeji, Y.

AU - Watanabe, A.

AU - Baba, H.

AU - Adachi, Y.

AU - Ichiyoshi, Y.

AU - Korenaga, D.

AU - Sugimachi, K.

PY - 1996/5/31

Y1 - 1996/5/31

N2 - Colorectal cancer is one of the most serious diseases of our time. Recent progress in its treatment is reviewed in this paper. There are many approaches for treating colorectal cancer; extended surgery to function-preserving surgery. The aim of surgical treatment is to excise the tumor completely, so extended surgery has been performed for curative resection of colorectal cancer. However, the quality of life (QOL) of the patients has been extremely impaired. In recent years, surgical treatments for avoiding colostomy, and urinary and sexual difficulties have been widely carried out, and QOL of the patients could be maintained in the postoperative period. Stage oriented therapy is accepted as the concept of surgical treatment of colorectal cancer. For further improving the clinical results of colorectal cancer, we advocated 'type-oriented therapy' which is based on the biological characteristics of colorectal cancer, by determining i.e., p53 abnormalities of cancer cells, serum p53 antibodies, micrometastasis in the bone marrow and/or sensitivity to anticancer drugs.

AB - Colorectal cancer is one of the most serious diseases of our time. Recent progress in its treatment is reviewed in this paper. There are many approaches for treating colorectal cancer; extended surgery to function-preserving surgery. The aim of surgical treatment is to excise the tumor completely, so extended surgery has been performed for curative resection of colorectal cancer. However, the quality of life (QOL) of the patients has been extremely impaired. In recent years, surgical treatments for avoiding colostomy, and urinary and sexual difficulties have been widely carried out, and QOL of the patients could be maintained in the postoperative period. Stage oriented therapy is accepted as the concept of surgical treatment of colorectal cancer. For further improving the clinical results of colorectal cancer, we advocated 'type-oriented therapy' which is based on the biological characteristics of colorectal cancer, by determining i.e., p53 abnormalities of cancer cells, serum p53 antibodies, micrometastasis in the bone marrow and/or sensitivity to anticancer drugs.

UR - http://www.scopus.com/inward/record.url?scp=0029927671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029927671&partnerID=8YFLogxK

M3 - Article

C2 - 8678508

AN - SCOPUS:0029927671

VL - 23

SP - 517

EP - 528

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 5

ER -